tradingkey.logo

GSK CEO Miels Says GLP-1 Space Going To Be 'Very Crowded', Vaccines Remains Core Pillar For Drugmaker

ReutersFeb 4, 2026 11:25 AM

- GSK GSK.L CEO LUKE MIELS:

  • WE'RE GOING TO ACCELERATE KEY ASSETS IN OUR LATE STAGE PORTFOLIO - MEDIA CALL

  • WE NEED TO ACCELERATE WHAT WE HAVE AND TO ADD TO IT VIA SMART BUSINESS DEVELOPMENT - MEDIA CALL

  • WE'RE GOING TO BE MORE DYNAMIC ABOUT SHIFTING RESOURCES BEHIND PARTICULAR PROGRAMS - MEDIA CALL

  • BASIC FRAMEWORK THAT WE LIKE FOR BUSINESS DEVELOPMENT IS IN THAT 2 TO 4 BILLION POUNDS RANGE - MEDIA CALL

  • IN TERMS OF CAPITAL ALLOCATION STRATEGY, NUMBER ONE PRIORITY IS RESEARCH AND DEVELOPMENT AND BUSINESS DEVELOPMENT - MEDIA CALL

  • VACCINES REMAINS A CORE PILLAR FOR THE COMPANY

  • GLP-1 SPACE IS "GOING TO BE VERY CROWDED"

  • STRATEGICALLY FOR US OUR FOCUS IS MORE ON DOWNSTREAM EFFECTS OF OBESITY RATHER THAN ADDRESSING ACTUAL OBESITY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI